EGF treatment also markedly reduced cell proliferation rates, as indicated by Ki67 immunohistochemistry, in xenograft tumor tissue, indicating that EGF attenuated tumor growth in vivo as well as in vitro. This evidence concerns the gene EGF and neoplasm.